These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 25684421

  • 1. Synthesis and biological evaluation of 4-nitroindole derivatives as 5-HT2A receptor antagonists.
    Hayat F, Viswanath AN, Pae AN, Rhim H, Park WK, Choo HY.
    Bioorg Med Chem; 2015 Mar 15; 23(6):1313-20. PubMed ID: 25684421
    [Abstract] [Full Text] [Related]

  • 2. Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold.
    Deng X, Guo L, Xu L, Zhen X, Yu K, Zhao W, Fu W.
    Bioorg Med Chem Lett; 2015 Sep 15; 25(18):3970-4. PubMed ID: 26227779
    [Abstract] [Full Text] [Related]

  • 3. 5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives.
    Ostrowska K, Grzeszczuk D, Głuch-Lutwin M, Gryboś A, Siwek A, Leśniak A, Sacharczuk M, Trzaskowski B.
    Bioorg Med Chem; 2018 Jan 15; 26(2):527-535. PubMed ID: 29269256
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.
    Carro L, Torrado M, Raviña E, Masaguer CF, Lage S, Brea J, Loza MI.
    Eur J Med Chem; 2014 Jan 15; 71():237-49. PubMed ID: 24316025
    [Abstract] [Full Text] [Related]

  • 6. Proof of concept study for designed multiple ligands targeting the dopamine D2, serotonin 5-HT2A, and muscarinic M1 acetylcholine receptors.
    Szabo M, Lim HD, Herenbrink CK, Christopoulos A, Lane JR, Capuano B.
    J Med Chem; 2015 Feb 12; 58(3):1550-5. PubMed ID: 25590655
    [Abstract] [Full Text] [Related]

  • 7. Structure-based design of PDZ ligands as inhibitors of 5-HT(2A) receptor/PSD-95 PDZ1 domain interaction possessing anti-hyperalgesic activity.
    Vogrig A, Dorr L, Bouzidi N, Boucherle B, Wattiez AS, Cassier E, Vallon G, Ripoche I, Abrunhosa-Thomas I, Marin P, Nauton L, Thery V, Courteix C, Lian LY, Ducki S.
    ACS Chem Biol; 2013 Oct 18; 8(10):2209-16. PubMed ID: 23895101
    [Abstract] [Full Text] [Related]

  • 8. Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.
    Gianotti M, Botta M, Brough S, Carletti R, Castiglioni E, Corti C, Dal-Cin M, Delle Fratte S, Korajac D, Lovric M, Merlo G, Mesic M, Pavone F, Piccoli L, Rast S, Roscic M, Sava A, Smehil M, Stasi L, Togninelli A, Wigglesworth MJ.
    J Med Chem; 2010 Nov 11; 53(21):7778-95. PubMed ID: 20942472
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and preliminary in vitro and in vivo pharmacological evaluation of 2-{4-[4-(2,5-disubstituted thiazol-4-yl)phenylethyl]piperazin-1-yl}-1,8-naphthyridine-3-carbonitriles as atypical antipsychotic agents.
    Gowri Chandra Sekhar KV, Rao VS, Deuther-Conrad W, Reddy AS, Brust P, Krishna Kumar MM.
    J Enzyme Inhib Med Chem; 2011 Aug 11; 26(4):561-8. PubMed ID: 21171898
    [Abstract] [Full Text] [Related]

  • 11. C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.
    Kapadia N, Harding WW.
    Bioorg Med Chem Lett; 2015 Sep 01; 25(17):3451-4. PubMed ID: 26227772
    [Abstract] [Full Text] [Related]

  • 12. Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
    Seo HJ, Park EJ, Kim MJ, Kang SY, Lee SH, Kim HJ, Lee KN, Jung ME, Lee M, Kim MS, Son EJ, Park WK, Kim J, Lee J.
    J Med Chem; 2011 Sep 22; 54(18):6305-18. PubMed ID: 21823597
    [Abstract] [Full Text] [Related]

  • 13. Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT2A/mGlu2 Receptor Complex.
    Poulie CBM, Liu N, Jensen AA, Bunch L.
    J Med Chem; 2020 Sep 10; 63(17):9928-9949. PubMed ID: 32815361
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors.
    Acuña-Castillo C, Villalobos C, Moya PR, Sáez P, Cassels BK, Huidobro-Toro JP.
    Br J Pharmacol; 2002 Jun 10; 136(4):510-9. PubMed ID: 12055129
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands.
    Chang-Fong J, Tyacke RJ, Lau A, Westaway J, Hudson AL, Glennon RA.
    Bioorg Med Chem Lett; 2004 Feb 23; 14(4):1003-5. PubMed ID: 15013010
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT2A receptor (5-HT2AR) antagonist M100907.
    Gilbertson SR, Chen YC, Soto CA, Yang Y, Rice KC, Cunningham KA, Anastasio NC.
    Bioorg Med Chem Lett; 2018 May 01; 28(8):1381-1385. PubMed ID: 29555153
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.